Miltefosine

Miltefosine

SCHEMBL20769827

CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C.CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 1.00
AKT1 P31749 2/20 1.00
ESR1 P03372 1/20 1.00
ADORA3 P0DMS8 1/20 1.00
CDC25A P30304 1/20 1.00
AGTR1 P30556 1/20 1.00
ADRA1A P35348 1/20 1.00
KCNH2 Q12809 1/20 1.00
SMN1; SMN2 Q16637 2/20 0.69
PRKD3 O94806 1/20 0.69
PRKCG P05129 1/20 0.69
PRKCB P05771 1/20 0.69
PRKCA P17252 1/20 0.69
PRKCH P24723 1/20 0.69
PRKCI P41743 1/20 0.69
PRKCE Q02156 1/20 0.69
PRKCQ Q04759 1/20 0.69
PRKCZ Q05513 1/20 0.69
PRKCD Q05655 1/20 0.69
PRKD1 Q15139 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10415264 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL4166195 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL596694 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
Miltefosine SCHEMBL26215 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
Octadecylphosphonocholine SCHEMBL744376 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
Tetradecylphosphocholine SCHEMBL5481590 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL29465558 1.00 LMNA (1.00) LMNAAKT1ESR1ADORA3CDC25A
Miltefosine SCHEMBL7189058 0.98 LMNA (0.97) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL9234856 0.98 LMNA (0.96) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10934123 0.94 LMNA (0.88) LMNAAKT1ESR1ADORA3CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675838-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS Puretecch LYT, Inc. (US) 2020-07-08 EP disclosed
WO-2019046491-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS ARIYA THERAPEUTICS, INC. (US) 2019-03-07 WO disclosed